Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein

Journal of Clinical Lipidology

Volumn 4, Issue 5, 2010, Pages 382-388

  Smith, Jonathan D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Apolipoprotein A I; Cholesterol efflux; High density lipoprotein; Inflammation; Lipopolysaccharide; Reverse cholesterol transport

Indexed keywords

APOLIPOPROTEIN A1; ENDOTOXIN; HIGH DENSITY LIPOPROTEIN; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE;

ATHEROSCLEROSIS; CELL FUNCTION; CHOLESTEROL TRANSPORT; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; HUMAN; INFECTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; RISK FACTOR;

ANIMALS; APOLIPOPROTEIN A-I; CORONARY ARTERY DISEASE; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; LIPOPROTEINS, HDL; MICE; OXIDATION-REDUCTION; PEROXIDASE; RISK FACTORS;

BACTERIA (MICROORGANISMS); MUS;

EID: 77957875471     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2010.08.007     Document Type: Conference Paper

References (35)

1. D.J. Gordon, J.L. Probstfield, and R.J. Garrison High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 79 1989 8 15
2. A.R. Tall Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins J Intern Med 263 2008 256 273
3. M. Navab, S.S. Imes, and S.Y. Hama Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein J Clin Invest 88 1991 2039 2046
4. M. Navab, S.Y. Hama, G.P. Hough, G. Subbanagounder, S.T. Reddy, and A.M. Fogelman A cell-free assay for detecting HDL that is dysfunctional in preventing the formation of or inactivating oxidized phospholipids J Lipid Res 42 2001 1308 1317
5. B.J. Van Lenten, S.Y. Hama, and F.C. de Beer Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures J Clin Invest 96 1995 2758 2767
6. B.J. Ansell, M. Navab, and S. Hama Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment Circulation 108 2003 2751 2756
7. M. de la Llera-Moya, D. Drazul-Schrader, B.F. Asztalos, M. Cuchel, D.J. Rader, and G.H. Rothblat The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages Arterioscler Thromb Vasc Biol 30 2010 796 801
8. W. Annema, N. Nijstad, and M. Tolle Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2) J Lipid Res 51 2010 743 754
9. A. Undurti, Y. Huang, J.A. Lupica, J.D. Smith, J.A. Didonato, and S.L. Hazen Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle J Biol Chem 284 2009 30825 30835
10. S.A. Sorrentino, C. Besler, and L. Rohrer Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy Circulation 121 2010 110 122
11. D.R. van der Westhuyzen, F.C. de Beer, and N.R. Webb HDL cholesterol transport during inflammation Curr Opin Lipidol 18 2007 147 151
12. W.S. Davidson, R.A. Silva, S. Chantepie, W.R. Lagor, M.J. Chapman, and A. Kontush Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters. Relevance to antioxidative function Arterioscler Thromb Vasc Biol 29 2009 870 876
13. L.W. Castellani, M. Navab, and B.J. Van Lenten Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles J Clin Invest 100 1997 464 474
14. B.J. Van Lenten, A.C. Wagner, D.P. Nayak, S. Hama, M. Navab, and A.M. Fogelman High-density lipoprotein loses its anti-inflammatory properties during acute influenza a infection Circulation 103 2001 2283 2288
15. A. Pirillo, P. Uboldi, C. Bolego, H. Kuhn, and A.L. Catapano The 15-lipoxygenase-modified high density lipoproteins 3 fail to inhibit the TNF-alpha-induced inflammatory response in human endothelial cells J Immunol 181 2008 2821 2830
16. L. Zheng, B. Nukuna, and M.L. Brennan Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease J Clin Invest 114 2004 529 541
17. A. Daugherty, J.L. Dunn, D.L. Rateri, and J.W. Heinecke Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions J Clin Invest 94 1994 437 444
18. M.L. Brennan, M.S. Penn, and F. Van Lente Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 2003 1595 1604
19. D.Q. Peng, Z. Wu, G. Brubaker, and L. Zheng Tyrosine modification is not required for myeloperoxidase-induced loss of apolipoprotein A-I functional activities J Biol Chem 280 2005 33775 33784
20. L. Zheng, M. Settle, and G. Brubaker Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages J Biol Chem 280 2005 38 47
21. D.Q. Peng, G. Brubaker, and Z. Wu Apolipoprotein A-I Tryptophan substitution leads to resistance to myeloperoxidase-mediated loss of function Arterioscler Thromb Vasc Biol 28 2008 2063 2070
22. C. Bergt, K. Oettl, W. Keller, F. Andreae, H.J. Leis, E. Malle, and W. Sattler Reagent or myeloperoxidase-generated hypochlorite affects discrete regions in lipid-free and lipid-associated human apolipoprotein A-I Biochem J 346 Pt 2 2000 345 354
23. S.L. Hazen, and J.W. Heinecke 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima J Clin Invest 99 1997 2075 2081
24. S. Pennathur, C. Bergt, and B. Shao Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species J Biol Chem 279 2004 42977 42983
25. C. Bergt, S. Pennathur, and X. Fu The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport Proc Natl Acad Sci U S A 101 2004 13032 13037
26. B. Shao, M.N. Oda, and C. Bergt Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I J Biol Chem 281 2006 9001 9004
27. U. Panzenbock, L. Kritharides, M. Raftery, K.A. Rye, and R. Stocker Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I J Biol Chem 275 2000 19536 19544
28. G. Brubaker, D.Q. Peng, B. Somerlot, D.J. Abdollahian, and J.D. Smith Apolipoprotein A-I lysine modification: effects on helical content, lipid binding and cholesterol acceptor activity Biochim Biophys Acta 1761 2006 64 72
29. Z. Wu, M.A. Wagner, and L. Zheng The refined structure of nascent HDL reveals a key functional domain for particle maturation and dysfunction Nat Struct Mol Biol 14 2007 861 868
30. B. Shao, G. Cavigiolio, N. Brot, M.N. Oda, and J.W. Heinecke Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I Proc Natl Acad Sci U S A 105 2008 12224 12229
31. F.C. McGillicuddy, M.M. de la Llera, and C.C. Hinkle Inflammation impairs reverse cholesterol transport in vivo Circulation 119 2009 1135 1145
32. W. Khovidhunkit, A.H. Moser, J.K. Shigenaga, C. Grunfeld, and K.R. Feingold Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine macrophages: differential role of LXR J Lipid Res 44 2003 1728 1736
33. Y. Zhang, I. Zanotti, M.P. Reilly, J.M. Glick, G.H. Rothblat, and D.J. Rader Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo Circulation 108 2003 661 663
34. J.D. Smith Inflammation impairs reverse cholesterol transport in vivo Circulation 118 2008 S453
35. P. Malik, and J.D. Smith A novel in vivo assay for reverse cholesterol transport Arterioscler Thromb Vasc Biol 29 2009 e46